The present invention is directed toward wearable defibrillators and, more particularly, toward wearable defibrillators capable of detecting the motion and/or position of a patient wearing the wearable defibrillator and using the sensed motion and/or position to determine an appropriate treatment.
The wearable defibrillator consists of a monitor and a vest (or belt) which are both worn by the patient. The device monitors the patient's ECG with sensing electrodes, such as 10a, 10b, 10c, 10d, to detect life-threatening arrhythmias and delivers a cardioverting or defibrillating shock through therapy pads, such as 18, if treatment is needed.
There is also a third piece of equipment called the battery charger that can provide two functionalities: first it can charge the monitor batteries, 41, and second it can provide a gateway for the monitor to download data to a central server. The monitor can communicate to the charger through a wireless Bluetooth link and the charger can connect to a central server through the internet.
The accelerometer(s) can allow for the computer in the wearable defibrillator to determine the position of the monitor, belt and/or patient, and the corresponding applied forces. This information can be used in a confidence based arrhythmia detection algorithm to accelerate the timing to hasten the occurrence of or hold off therapy based on past and present body motion and/or position history.
Other devices that could be used instead of an accelerometer would include, but are not limited to: gyroscope, magnetometer, hall-effect devices, and other force motion or position sensors.
Accelerometers are able to measure x, y, and z positions. This improvement covers having an accelerometer in either the belt, which is worn on the patient's upper body, or in the monitor, which is worn on the patient's lower body; or both locations; or other positions on the patient.
The accelerometer in the belt can be used to determine patient position since it is located on the upper torso of the patient. As a result, the belt accelerometer will be chosen such that high sensitivity data can be measured or determined from possible body positions (e.g. patient position). The accelerometer in the monitor can be chosen so that high sensitivity data (such as breathing or other minor motion) can be measured; low sensitivity data (such as mechanical shock) can also be measured; or both. Additional accelerometers can also be used so that both low sensitivity and high sensitivity data can be measured, or an accelerometer capable of both low sensitivity and high sensitivity can be used.
Some embodiments of the invention include a patient wearable treatment device having treatment elements adjacent to said patient in proximity to said patient's skin, and at least one patient motion detector connected to the device and generating a signal indicative of patient activity, and at least one control to evaluate signals from said motion detectors to determine if said signal is indicative of patient activity appropriate for treatment.
Embodiments include using at least one accelerometer including at least one multi-axis accelerometer and can include two three-axis accelerometers with one of said accelerometers mounted on a patient vest portion and another of said accelerometers is mounted on the monitor or other portion. Some embodiments can include a visual display on said monitor portion where the orientation of said visual display is controlled by the output of said accelerometer.
The body orientation of the patient is determined by the output of at least one accelerometer including standing and prone.
Treatment can be accelerated or delayed based upon the output of the motion detector.
The invention can detect a patient condition based upon the level of activity of a patient over a period of time based upon said stored output of said accelerometer, and can be used to detect conditions such as, for example, congestive heart failure or sleep disorders.
A method of cardiac treatment of a patient including sensing a cardiac condition, sensing patient motion with sensors such as, for example, accelerometers worn by said patient and evaluating said sensed patient activity to determine treatment is appropriate to said cardiac condition.
Embodiments can detect vertical and prone positions and determine a patient activity and a patient body orientation.
The following is a list of the functionality, information that can be provided by the motion detection or accelerometers:
Patient body state: Patient is vertical, Patient is horizontal (On left side, On right side).
Patient is moving in repetitive pattern: Vibrating (environmental), Convulsing.
Patient is accelerating: Patient is falling.
Equipment (belt and monitor) state: x/y/z position.
Equipment acceleration.
Equipment mechanical shock (high force impact, acceleration).
Verification of tactile motor operation in belt node.
In this embodiment, two accelerometers 16, 17 are used. One accelerometer 17 is located on the node device 11 and a second 16 is used on the monitor 15. It is understood that some embodiments will use a single accelerometer or position/force/motion detector, and still other embodiments may use three or more. Using multiple sensors permit the treatment algorithm to evaluate accelerometer (sensor) differentials to predict patient activity and accelerometer reliability. The use of multiple accelerometers permit separate evaluation of different patient movements and comparing such separate movements to best determine patient activity and equipment function. The actual treatment algorithm used will usually depend upon the diagnostic requirement of each individual doctor and the condition(s) he wishes to monitor. Any or all of the activities determined by the invention can be used. These can be combined with other inputs.
Patient Movement During Arrhythmia
The use of accelerometers can be used to determine a patient's body state during the detection of an arrhythmia. It also may be used to detect if a mechanically noisy environment is the cause of an erroneous arrhythmia detection.
Patient Movement Used in the Confidence Algorithm Factor
A confidence algorithm, which is influenced by many inputs including the patient's body state as determined by the accelerometers, is used to determine if a patient's heart arrhythmias requires defibrillation.
Generally, cardiac treatment is not required if the patient is conscious. By using accelerometers the patient body state can be monitored. If there has been no change in patient body state for a period of time as detected by the accelerometer(s) then there will be an increased confidence of the algorithm that the patient is unconscious. If a change in patient body state has been detected by the accelerometer(s) then there will be a decreased confidence of the algorithm that the patient is unconscious. The wearable defibrillator can hasten its decision to apply treatment if a high level of confidence exists that the patient is unconscious. If patient motion is detected while other sensors and algorithms indicate that a treatable rhythm is present, treatment delivery can be delayed to provide the patient additional time to respond to system messaging.
False Arrhythmia Detection Due to Physical Motion
Sometimes a false arrhythmia is detected by the system due to physical motion, i.e. electrode or cables moving against the body or clothing, which creates false deviations in the patient's ECG. If an arrhythmia is detected and vibration or high patient/equipment acceleration is detected then the patient can be alerted to this condition. The tactile stimulator may be turned on or the audio volume may be increased to notify the patient reference 1. This information may also be applied to the treatment confidence algorithm thereby causing a decrease in confidence given that the physical motion can cause a false positive detection. Use of the accelerometer (s) can reduce undesired treatment of false arrhythmias.
Correlation of ECG Artifact with Belt Motion
Motion of the electrode belt may cause interference with ECG signal pickup and possible false detections. The signals obtained from the accelerometer can be correlated with an ECG signal to determine if ECG signal contamination exists. The quality of the correlation can be used as an additional confidence factor in the arrhythmia detection algorithm. If an arrhythmia is detected and there is a high degree of correlation between the ECG signal and the accelerometer signal the confidence in the arrhythmia detection can be reduced. No signal correlation indicates increased confidence that the arrhythmia detection is accurate.
Treatment Verification
The accelerometers may also be used to verify that a treatment has been applied by detecting sudden movements or muscle spasms in a patient immediately following the treatment. Often after defibrillation a patient's muscles spasm from the energy pulse. The muscle spasm will cause detectable movements on the accelerometers similar to convulsing.
Detection of Bystanders/Unsuccessful Defibrillation
Post shock motion of the patient after several unsuccessful defibrillation attempts may indicate the presence of bystanders. The bystanders could be rescue personnel such as an EMT.
In this case special alarms or voice messages could be generated to inform the bystander of the equipment and treatment status. Additional shocks could be delayed or cancelled to prevent a shock to the bystanders or rescue personnel.
Post Shock Motion Detection
When a shock is delivered the patient may move suddenly and then return to a state where there is a lack of motion. If no further motion is detected a high confidence can exist that the arrhythmia is still present. This information can be used as an additional post-shock confidence factor for the detection algorithm and that a continuing condition exists. If post-shock motion continues or if the patient body position changes from a horizontal to vertical position, there is high confidence that the defibrillation was successful and additional shocks can be delayed.
Belt Quality Feedback
Overall belt quality can be examined by gathering data using the accelerometers during certain failure states such as electrode fall-off and therapy pad fall-off detection.
Reduce Electrode and Therapy Pad Fall-Offs
If one of the electrodes 10 or therapy pads 18 fall off of the patient, then the system will record the patient body state during the fall-off event. Patient positions include sitting up, lying down; left side, right side. If vibration or patient falling is detected then that would also be recorded as well since it might be the cause of the falloff event.
Over time the data can be analyzed and used to determine positions that may tend to cause fall-offs. This information can then be used to improve the belt design reducing and possibly eliminating the fall-offs in those certain activities or positions.
An example would be if post analysis of data over a several month period of time shows that 75% of ECG fall-offs occur when the patient is laying on their left side then the belt design on the left side could be examined to determine what might be making it susceptible to fall-offs in that patient position.
Provide Recommendations to Patients
Accelerometers data collected over time could also be used to inform new patients of patient's body states that tend to be more comfortable. Patients who have worn the device for an extended time will most likely have experimented with different positions (sleeping positions, sitting positions, etc.) and will tend to use the most comfortable ones. This data can be recorded and used to improve the belt for the other positions and also provide recommendations to new patients.
Improve Belt Comfort
The accelerometer data collected during patient use can be used to improve the comfort of the belt by studying patient sleep habits, or habits during other selected activities.
If 80% of the patients tend to sleep on their right side then the assumption can be made that something about the belt makes it less comfortable for the patients to lie on their left side. With this information research can be performed to determine what about that position causes the belt to be uncomfortable and engineering can be performed to improve the belt comfort.
Belt Self Diagnostics
Self diagnostics may also be provided such as Belt Node Tactile Stimulator (vibration/acceleration) self test.
The tactile stimulator 12 (a patient notification device) is a motor with an unbalancing weight on its shaft. When the motor is on it causes the belt to vibrate much like a cell-phone in vibration mode.
When the tactile is activated the accelerometer 17 in the node can be used to verify that the node is vibrating which means that the tactile is working.
Patient Notification of Physical Events
The accelerometers can be used to provide feedback to the patient regarding certain mechanical events. They may also be used to adjust the device audio volume outputs based on the current state of the patient.
Equipment Abuse Notification
If certain mechanical conditions that may lead to equipment damage such as mechanical shock or vibration are detected by the accelerometers then the system can notify the patient of such conditions and advise the patient by the monitor computer screen on 15 of the condition.
If the monitor or belt is dropped or if they are hit with some other object causing a force greater than a predefined acceptable force, then the monitor will provide either an audio or visual (display) indication to the patient that the event has occurred and warn against allowing such an event to occur again.
If continuous vibration above a certain predefined acceptable threshold is detected for a period of time then the monitor on 15 may also provide a warning to the patient. Such vibration could lead to electrode or therapy pad fall-off or even cause false arrhythmia detection if enough physical motion is applied to the electrode and cables.
Adjust Device Alarm Volumes
If the accelerometers have recorded the patient body state to be unchanged for an extended time and the patient is either lying or sitting down then the monitor will assume the patient is sleeping and will then increase the audio volume output of any audio message if necessary to awaken the patient. The monitor may also enable the tactile stimulator to awaken the patient in the event of a critical audio message.
Adjust Display Rotation
The monitor accelerometer can be used to determine the proper rotation of the system display or LCD output on 15. The monitor 15 contains a display that can either be used to deliver a visual message to the patient or for initial patient setup by care givers. For patient visual messages, since the monitor is positioned approximately at the patient's mid section, the display would be upside down (rotated 180 degrees) with respect to the monitor. However, during patient setup, the monitor could be held right side up in front of the skilled personnel. As a result, the display would be right side up. The monitor accelerometer data can be used to adjust the display accordingly depending on how the display is attempting to be read.
Detect Equipment Abuse
Detect equipment abuse during use as well as during shipping. Equipment abuse can be determined by parameters such as number of times dropped and intensity. Detection of equipment abuse can trigger such actions as internal diagnostics, auto download, and equipment service recommendations.
Equipment Drop Detection
If the accelerometers detect a mechanical shock above a pre-determined acceptable threshold then the monitor will record a drop event. Other parameters such as date/time stamp and current operating mode will be recorded as well.
The date/time stamp should allow correlation between the monitor location and the damaging event allowing further information to be obtained using the carrier tracking numbers if such damage occurred during shipping.
If it is not during shipping and is during patient use and there is some form of equipment malfunction after the drop then that could be tied to the root cause of the equipment failure. Such information could be used to advice patients of the types of mechanical shocks that may damage the equipment. It also may be used to improve the robustness of the equipment to survive such forces in the future.
Equipment Service Recommendation
If the monitor accelerometer 16, belt accelerometer 17 have recorded a mechanical shock above a predefined acceptable threshold or if a predefined acceptable number of mechanical shocks has occurred then the monitor will recommend with an audio or visual (display) message via 15 to the patient that the equipment should be serviced. The monitor on 15 will also, during the next download, notify the manufacturer that it should be serviced.
Internal Diagnostics
If the accelerometer does detect an excessive mechanical shock on the belt or monitor then it may initiate internal self-diagnostics. Both the monitor 15 and node 11 have built-in circuitry as shown in
Auto Download to Manufacturer
If there is a significant mechanical shock to the belt or monitor then the monitor may immediately initiate an automatic download to the manufacturer requesting service.
Monitor Patient Activity Over Time
Accelerometer data can be measured and stored over time to study patient activity. Patient activity data can be used to provide feedback to doctors about a patient's specific condition.
Patient Activity Data and Treatment
After a treatment event, patient activity data taken before, up to, and including the event can be downloaded. This data can be collected among patients and used to make correlations between patient activity derived from accelerometers 16, 17 and the probability of a possible treatment event occurring. These correlations can be used to take precautionary measures with patients who have similar activities as those who had past treatment events.
Patient Activity Data and Doctor Feedback
Patient activity data can be used over a period of time by doctors or data evaluation systems to determine if proper patient activity levels are met. Examples to study would be extremely low patient activity; patient performing recommended exercises; and/or patient real time activity level and corresponding heart rate data. Patients who are experiencing congestive heart failure can be monitored for physical activity and at rest body position. Gradual reduction in patient activity indicated by lack of motion can indicate a worsening of the congestive heart failure condition. Body position at rest can also indicate patient deterioration if body position at rest is primarily vertical since congestive heart failure patients may have difficulty resting in a horizontal position.
An arrhythmia detection algorithm can be implemented by assigning various confidence coefficients or weighting values to the various detectors used by the algorithm. This can be done prior to using the motion detection confidence algorithm. For example, the monitor can be designed with two independent ECG data streams for analysis. The algorithm can execute independent algorithms on each data stream that analyze the signal to extract heart rate, morphology, frequency information, and other information. Additional analysis is performed, independently on each channel, to analyze the signal for noise contamination that may result from patient motion or biological signals such as muscle noise. Other secondary inputs to the basic detection algorithm can include a patient response button and inputs from the accelerometers.
A weighting value can be assigned to each detector, response button and accelerometer and the combination for all detectors can be used to make the decision that a treatable arrhythmia condition exists. In addition, the weighting values can be used to manipulate the timing of therapy delivery.
The action of the algorithm in the presence of a noisy ECG channel could be to place more weight on the heart rate detector in the clean ECG channel. For the accelerometer enhanced confidence algorithm, a weighting could be assigned that would delay delivery of treatment while patient motion is detected as shown in the flow diagram of
The flow diagram in
As it will usually be desirable to track and store data in the patient wearable device, the addition of motion data can also be stored, tracked and evaluated. One such use would be to evaluate historical motion/activity levels to detect conditions such as congestive heart failure. Such diseases are often found in patients who would be wearing a cardiac treatment device.
This Application is a Continuation of U.S. patent application Ser. No. 15/187,952, titled “Wearable Medical Treatment Device With Motion/Position Detection”, filed on Jun. 21, 2016, which is a Continuation of U.S. patent application Ser. No. 14/180,775 (now U.S. Pat. No. 9,398,859), titled “Wearable Medical Treatment Device With Motion/Position Detection”, filed on Feb. 14, 2014, which is a Continuation of U.S. patent application Ser. No. 12/840,633 (now U.S. Pat. No. 8,676,313), titled “Wearable Medical Treatment Device With Motion/Position Detection”, filed on Jul. 21, 2010, which is a Continuation of U.S. patent application Ser. No. 12/002,469 (now U.S. Pat. No. 7,974,689), titled “Wearable Medical Treatment Device With Motion/Position Detection”, filed on Dec. 17, 2007, each of which is hereby incorporated herein by reference in its entirety. U.S. application Ser. No. 12/002,469 claims the benefit of U.S. Provisional Patent Application Ser. No. 60/934,404 titled “Wearable Medical Treatment Device With Motion/Position Detection”, filed on Jun. 13, 2007. The following U.S. patents are hereby incorporated by reference: U.S. Pat. Nos. 4,928,690, 6,065,154, 5,944,669, 5,741,306, 6,681,003, 6,253,099, and 5,078,134.
Number | Name | Date | Kind |
---|---|---|---|
4094310 | McEachern et al. | Jun 1978 | A |
4432368 | Russek | Feb 1984 | A |
4632122 | Johansson et al. | Dec 1986 | A |
4698848 | Buckley | Oct 1987 | A |
4928690 | Heilman et al. | May 1990 | A |
4978926 | Zerod et al. | Dec 1990 | A |
5062834 | Gross et al. | Nov 1991 | A |
5078134 | Heilman | Jan 1992 | A |
5176380 | Evans et al. | Jan 1993 | A |
5330505 | Cohen | Jul 1994 | A |
5348008 | Bomn et al. | Sep 1994 | A |
5353793 | Bomn | Oct 1994 | A |
5357696 | Gray et al. | Oct 1994 | A |
5365932 | Greenhut | Nov 1994 | A |
5544661 | Davis et al. | Aug 1996 | A |
5564429 | Bomn et al. | Oct 1996 | A |
5662689 | Elsberry et al. | Sep 1997 | A |
5718242 | McClure et al. | Feb 1998 | A |
5738102 | Lemelson | Apr 1998 | A |
5741306 | Glegyak et al. | Apr 1998 | A |
5758443 | Pedrazzini | Jun 1998 | A |
5792190 | Olson et al. | Aug 1998 | A |
5929601 | Kaib et al. | Jul 1999 | A |
5944669 | Kaib | Aug 1999 | A |
6016445 | Baura | Jan 2000 | A |
6045503 | Grabner et al. | Apr 2000 | A |
6049730 | Kristbjarnarson | Apr 2000 | A |
6065154 | Hulings et al. | May 2000 | A |
6097987 | Milani | Aug 2000 | A |
6148233 | Owen et al. | Nov 2000 | A |
6169387 | Kaib | Jan 2001 | B1 |
6169397 | Steinbach et al. | Jan 2001 | B1 |
6253099 | Oskin et al. | Jun 2001 | B1 |
6280461 | Glegyak et al. | Aug 2001 | B1 |
6390996 | Halperin et al. | May 2002 | B1 |
6406426 | Reuss et al. | Jun 2002 | B1 |
6666830 | Lehrman et al. | Dec 2003 | B1 |
6681003 | Linder et al. | Jan 2004 | B2 |
6690969 | Bystrom et al. | Feb 2004 | B2 |
6790178 | Mault et al. | Sep 2004 | B1 |
6804554 | Ujhelyi et al. | Oct 2004 | B2 |
6827695 | Palazzolo et al. | Dec 2004 | B2 |
6865413 | Halperin et al. | Mar 2005 | B2 |
6908437 | Bardy | Jun 2005 | B2 |
6990373 | Jayne et al. | Jan 2006 | B2 |
7074199 | Halperin et al. | Jul 2006 | B2 |
7108665 | Halperin et al. | Sep 2006 | B2 |
7118542 | Palazzolo et al. | Oct 2006 | B2 |
7122014 | Palazzolo et al. | Oct 2006 | B2 |
7149579 | Koh et al. | Dec 2006 | B1 |
7177684 | Kroll et al. | Feb 2007 | B1 |
7220235 | Geheb et al. | May 2007 | B2 |
7277752 | Matos | Oct 2007 | B2 |
7295871 | Halperin et al. | Nov 2007 | B2 |
7340296 | Stahmann et al. | Mar 2008 | B2 |
7427921 | Van Woudenberg | Sep 2008 | B2 |
7453354 | Reiter et al. | Nov 2008 | B2 |
7476206 | Palazzolo et al. | Jan 2009 | B2 |
7488293 | Marcovecchio et al. | Feb 2009 | B2 |
7702390 | Min | Apr 2010 | B1 |
7810172 | Williams | Oct 2010 | B2 |
7831303 | Rueter et al. | Nov 2010 | B2 |
7974689 | Volpe et al. | Jul 2011 | B2 |
8121683 | Bucher et al. | Feb 2012 | B2 |
8140154 | Donnelly et al. | Mar 2012 | B2 |
8271082 | Donnelly et al. | Sep 2012 | B2 |
8369944 | Macho et al. | Feb 2013 | B2 |
8600486 | Kaib et al. | Dec 2013 | B2 |
8649861 | Donnelly et al. | Feb 2014 | B2 |
8706215 | Kaib et al. | Apr 2014 | B2 |
8904214 | Volpe et al. | Dec 2014 | B2 |
8909335 | Radzelovage | Dec 2014 | B2 |
9008801 | Kalb et al. | Apr 2015 | B2 |
9135398 | Kaib et al. | Sep 2015 | B2 |
9398859 | Volpe et al. | Jul 2016 | B2 |
20020107435 | Swetlik et al. | Aug 2002 | A1 |
20030004547 | Owen et al. | Jan 2003 | A1 |
20030023277 | Owen et al. | Jan 2003 | A1 |
20030032988 | Fincke | Feb 2003 | A1 |
20030055460 | Owen et al. | Mar 2003 | A1 |
20030095648 | Kaib et al. | May 2003 | A1 |
20030149462 | White et al. | Aug 2003 | A1 |
20030158593 | Heilman et al. | Aug 2003 | A1 |
20030174049 | Beigel et al. | Sep 2003 | A1 |
20030195567 | Jayne et al. | Oct 2003 | A1 |
20030212311 | Nova et al. | Nov 2003 | A1 |
20030233129 | Matos | Dec 2003 | A1 |
20040007970 | Ma et al. | Jan 2004 | A1 |
20040049233 | Edwards | Mar 2004 | A1 |
20040133079 | Mazar | Jul 2004 | A1 |
20040143297 | Ramsey | Jul 2004 | A1 |
20050049515 | Misczynski et al. | Mar 2005 | A1 |
20050131465 | Freeman et al. | Jun 2005 | A1 |
20060017575 | McAdams | Jan 2006 | A1 |
20060036292 | Smith et al. | Feb 2006 | A1 |
20060085049 | Cory et al. | Apr 2006 | A1 |
20060129067 | Grajales et al. | Jun 2006 | A1 |
20060178706 | Lisogurski et al. | Aug 2006 | A1 |
20060220809 | Stigall et al. | Oct 2006 | A1 |
20060264776 | Stahmann et al. | Nov 2006 | A1 |
20060270952 | Freeman et al. | Nov 2006 | A1 |
20070073120 | Li et al. | Mar 2007 | A1 |
20070118056 | Wang et al. | May 2007 | A1 |
20070129769 | Bourget et al. | Jun 2007 | A1 |
20070161913 | Farrell et al. | Jul 2007 | A1 |
20070169364 | Townsend et al. | Jul 2007 | A1 |
20070239220 | Greenhut et al. | Oct 2007 | A1 |
20070265671 | Roberts et al. | Nov 2007 | A1 |
20070299474 | Brink | Dec 2007 | A1 |
20080004536 | Baxi et al. | Jan 2008 | A1 |
20080015454 | Gal | Jan 2008 | A1 |
20080030656 | Watson et al. | Feb 2008 | A1 |
20080031270 | Tran et al. | Feb 2008 | A1 |
20080033495 | Kumar | Feb 2008 | A1 |
20080045815 | Derchak et al. | Feb 2008 | A1 |
20080058884 | Matos | Mar 2008 | A1 |
20080221631 | Dupelle | Sep 2008 | A1 |
20080249591 | Gaw et al. | Oct 2008 | A1 |
20080287770 | Kurzweil et al. | Nov 2008 | A1 |
20080306562 | Donnelly et al. | Dec 2008 | A1 |
20080312520 | Rowlandson et al. | Dec 2008 | A1 |
20080312709 | Volpe et al. | Dec 2008 | A1 |
20090073991 | Landrum et al. | Mar 2009 | A1 |
20090076336 | Mazar et al. | Mar 2009 | A1 |
20090076340 | Libbus et al. | Mar 2009 | A1 |
20090076341 | James et al. | Mar 2009 | A1 |
20090076342 | Amurthur et al. | Mar 2009 | A1 |
20090076343 | James et al. | Mar 2009 | A1 |
20090076344 | Libbus et al. | Mar 2009 | A1 |
20090076345 | Manicka et al. | Mar 2009 | A1 |
20090076346 | James et al. | Mar 2009 | A1 |
20090076348 | Manicka et al. | Mar 2009 | A1 |
20090076349 | Libbus et al. | Mar 2009 | A1 |
20090076350 | Bly et al. | Mar 2009 | A1 |
20090076363 | Bly et al. | Mar 2009 | A1 |
20090076364 | Libbus et al. | Mar 2009 | A1 |
20090076397 | Libbus et al. | Mar 2009 | A1 |
20090076405 | Amurthur et al. | Mar 2009 | A1 |
20090076410 | Libbus et al. | Mar 2009 | A1 |
20090076559 | Libbus et al. | Mar 2009 | A1 |
20090082691 | Denison et al. | Mar 2009 | A1 |
20090093687 | Telfort et al. | Apr 2009 | A1 |
20090138059 | Ouwerkerk | May 2009 | A1 |
20090177100 | Ternes | Jul 2009 | A1 |
20090234410 | Libbus et al. | Sep 2009 | A1 |
20090264792 | Mazar | Oct 2009 | A1 |
20090275848 | Brockway et al. | Nov 2009 | A1 |
20090287120 | Ferren et al. | Nov 2009 | A1 |
20090292194 | Libbus et al. | Nov 2009 | A1 |
20100056881 | Libbus et al. | Mar 2010 | A1 |
20100069735 | Berkner | Mar 2010 | A1 |
20100076513 | Warren et al. | Mar 2010 | A1 |
20100076533 | Dar et al. | Mar 2010 | A1 |
20100083968 | Wondka et al. | Apr 2010 | A1 |
20100179438 | Heneghan et al. | Jul 2010 | A1 |
20100234715 | Shin et al. | Sep 2010 | A1 |
20100234716 | Engel | Sep 2010 | A1 |
20100295674 | Hsieh et al. | Nov 2010 | A1 |
20100298899 | Donnelly et al. | Nov 2010 | A1 |
20100312297 | Volpe et al. | Dec 2010 | A1 |
20110077728 | Li et al. | Mar 2011 | A1 |
20110196220 | Storm | Aug 2011 | A1 |
20110288604 | Kaib et al. | Nov 2011 | A1 |
20110288605 | Kaib et al. | Nov 2011 | A1 |
20120011382 | Volpe et al. | Jan 2012 | A1 |
20120112903 | Kaib et al. | May 2012 | A1 |
20120144551 | Guldalian | Jun 2012 | A1 |
20120146797 | Oskin et al. | Jun 2012 | A1 |
20120158074 | Hall | Jun 2012 | A1 |
20120158075 | Kaib et al. | Jun 2012 | A1 |
20130325078 | Whiting et al. | Dec 2013 | A1 |
20130325096 | Dupelle et al. | Dec 2013 | A1 |
20140163334 | Volpe et al. | Jun 2014 | A1 |
20140371806 | Raymond et al. | Dec 2014 | A1 |
20150005588 | Herken et al. | Jan 2015 | A1 |
20150039053 | Kaib et al. | Feb 2015 | A1 |
20150217121 | Subramanian et al. | Aug 2015 | A1 |
20150231403 | Kaib et al. | Aug 2015 | A1 |
20160143585 | Donnelly et al. | May 2016 | A1 |
Number | Date | Country |
---|---|---|
101031334 | Sep 2007 | CN |
101657229 | Feb 2010 | CN |
101848677 | Sep 2010 | CN |
0295497 | Sep 1993 | EP |
0335356 | Mar 1996 | EP |
1642616 | Apr 2006 | EP |
1455640 | Jan 2008 | EP |
1720446 | Jul 2010 | EP |
S6368135 | Mar 1988 | JP |
5115450 | May 1993 | JP |
H07541 | Jan 1995 | JP |
H10-28679 | Feb 1998 | JP |
H11319119 | Nov 1999 | JP |
2002-102361 | Apr 2002 | JP |
2002200059 | Jul 2002 | JP |
2002534231 | Oct 2002 | JP |
2003235997 | Aug 2003 | JP |
2004538066 | Dec 2004 | JP |
2005275606 | Oct 2005 | JP |
2007531592 | Nov 2007 | JP |
2008302228 | Dec 2008 | JP |
2009510276 | Mar 2009 | JP |
2009518057 | May 2009 | JP |
2009528909 | Aug 2009 | JP |
2010530114 | Sep 2010 | JP |
200002484 | Jan 2000 | WO |
2004054656 | Jul 2004 | WO |
2004067083 | Aug 2004 | WO |
2005082454 | Sep 2005 | WO |
2006050235 | May 2006 | WO |
2007019325 | Feb 2007 | WO |
20070057169 | May 2007 | WO |
2007077997 | Jul 2007 | WO |
2008137286 | Nov 2008 | WO |
2009034506 | Mar 2009 | WO |
2010014497 | Feb 2010 | WO |
2010025432 | Mar 2010 | WO |
2015127466 | Aug 2015 | WO |
Entry |
---|
American Journal of Respiratory and Critical Care Medicine, vol. 166, pp. 111-117 (2002). American Thoracic Society, ATS Statement Guidelines for the Six-Minute Walk Test, available at http://ajrccm.atsjournals.org/cgi/content/full/166/1/111. |
DeBock et al., “Captopril treatment of chronic heart failure in the very old,” J. Gerontol. (1994) 49: M148-M152. |
Extended European Search Report from corresponding European Application No. 11804401.5 dated May 18, 2016. |
Harnett, P.R. et al., “A Survey and Comparison of Laboratory Test Methods for Measuring Wicking”, Textile Research Journal, Jul. 1984. |
International Search Report dated Nov. 21, 2011 from corresponding International Application No. PCT/US11/43360. |
O'Keeffe et al., “Reproducability and responsiveness of quality of the assessment and six minute walk test in elderly heart failure patients,” Heart (1998) 80: 377-382. |
Search Report and Written Opinion from French counterpart application No. 0853856, dated Jan. 4, 2011. |
Number | Date | Country | |
---|---|---|---|
20180110419 A1 | Apr 2018 | US |
Number | Date | Country | |
---|---|---|---|
60934404 | Jun 2007 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15187952 | Jun 2016 | US |
Child | 15850435 | US | |
Parent | 14180775 | Feb 2014 | US |
Child | 15187952 | US | |
Parent | 12840633 | Jul 2010 | US |
Child | 14180775 | US | |
Parent | 12002469 | Dec 2007 | US |
Child | 12840633 | US |